Altered MT3 expression has been also reported in amyotrophic lateral sclerosis (ALS) [54], Down syndrome [132], pontosubicular necrosis [133], Parkinson's disease, meningitis, and Creutzfeld-Jakob disease [134]. Here, MT3 is linked to amyotrophic lateral sclerosis.